Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crinetics Pharmaceuticals (CRNX) Net Income: 2016-2024

Historic Net Income for Crinetics Pharmaceuticals (CRNX) over the last 9 years, with Dec 2024 value amounting to -$297.4 million.

  • Crinetics Pharmaceuticals' Net Income fell 69.33% to -$130.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$422.7 million, marking a year-over-year decrease of 54.83%. This contributed to the annual value of -$297.4 million for FY2024, which is 42.19% down from last year.
  • Crinetics Pharmaceuticals' Net Income amounted to -$297.4 million in FY2024, which was down 42.19% from -$209.2 million recorded in FY2023.
  • In the past 5 years, Crinetics Pharmaceuticals' Net Income registered a high of -$74.0 million during FY2020, and its lowest value of -$297.4 million during FY2024.
  • Moreover, its 3-year median value for Net Income was -$209.2 million (2023), whereas its average is -$223.4 million.
  • Data for Crinetics Pharmaceuticals' Net Income shows a maximum YoY slumped of 52.09% (in 2022) over the last 5 years.
  • Crinetics Pharmaceuticals' Net Income (Yearly) stood at -$74.0 million in 2020, then crashed by 45.41% to -$107.5 million in 2021, then tumbled by 52.09% to -$163.6 million in 2022, then fell by 27.88% to -$209.2 million in 2023, then crashed by 42.19% to -$297.4 million in 2024.